‌

US Patent 11708378 Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Date of Patent

July 25, 2023

0

Patent Application Number

172064880

Date Filed

March 19, 2021

0

Patent Citations

US Patent 8242116 Fused thiazole derivatives as kinase inhibitors

0

US Patent 8338592 Fused thiazole derivatives as kinase inhibitors

0

US Patent 8710054 Fused thiazole derivatives as kinase inhibitors

0

US Patent 8921361 Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probes

0

US Patent 8981087 Benzo [E] [1,3] oxazin-4-one derivatives as phosphoinositide 3-kinase inhibitors

0

US Patent 9200007 Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors

0

US Patent 9266879 Naphthridine derivatives as PI3K inhibitors for the treatment of cancer and immune-inflammatory disease

0

US Patent 9580442 Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors

0

...

Patent Primary Examiner

Rebecca L Anderson

0

CPC Code

0

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11708378 Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.